September 29, 2016 2:10 AM ET

Biotechnology

Company Overview of Progen Pharmaceuticals, Inc.

Company Overview

Progen Pharmaceuticals, Inc. discovers and develops small molecule pharmaceuticals for the treatment of anti-proliferation and cancer therapeutics. The company’s products are also used for the treatment of various diseases, including age-related macular degeneration, infectious diseases, inflammatory diseases, and vascular hyperplasia. Progen Pharmaceuticals, Inc. was formerly known as CellGate, Inc. and changed its name to Progen Pharmaceuticals, Inc. in February, 2008. The company was founded in 1998 and is based in Palo Alto, California. Progen Pharmaceuticals, Inc. operates as a subsidiary of TBG Diagnostics Limited.

2479 East Bayshore Road

Suite 709

Palo Alto, CA 94303

United States

Founded in 1998

Phone:

650-610-7800

Fax:

650-610-7801

Key Executives for Progen Pharmaceuticals, Inc.

Co-Founder and Director
Age: 73
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Progen Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.